CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

被引:9
|
作者
Williams, Alexis K. [1 ]
Klein, Melissa D. [2 ]
Martin, Jesse [1 ]
Weck, Karen E. [4 ]
Rossi, Joseph S. [2 ,3 ]
Stouffer, George A. [2 ,3 ]
Lee, Craig R. [1 ,3 ]
机构
[1] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC USA
[3] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源
关键词
cardiovascular diseases; clopidogrel; pharmacogenetics; precision medicine; IMPLEMENTATION;
D O I
10.1161/CIRCGEN.119.002441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:97 / 99
页数:3
相关论文
共 50 条
  • [21] CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke
    Kow, Chia Siang
    Zaihan, Abdullah Faiz
    Hasan, Syed Shahzad
    CLINICAL DRUG INVESTIGATION, 2021, 41 (01) : 115 - 116
  • [22] Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention
    Lee, Seung Hun
    Jeong, Young-Hoon
    Hong, David
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Hahn, Joo-Yong
    Choi, Seung-Hyuck
    Gwon, Hyeon-Cheol
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Joo, Hyung Joon
    Chang, Kiyuk
    Park, Yongwhi
    Ahn, Sung Gyun
    Suh, Jung-Won
    Lee, Sang Yeub
    Cho, Jung Rae
    Her, Ae-Young
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Lim, Do-Sun
    Shin, Eun-Seok
    Song, Young Bin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (07) : 829 - 843
  • [23] Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: A randomized control trial
    Xie, Xiang
    Ma, Yi-Tong
    Yang, Yi-Ning
    Li, Xiao-Mei
    Zheng, Ying-Ying
    Ma, Xiang
    Fu, Zhen-Yan
    Bayinsilema, Ba
    Li, Yan
    Yu, Zi-Xiang
    Chen, You
    Chen, Bang-Dang
    Liu, Fen
    Huang, Ying
    Liu, Cheng
    Baituola, Gulinaer
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3736 - 3740
  • [24] CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke
    Chia Siang Kow
    Abdullah Faiz Zaihan
    Syed Shahzad Hasan
    Clinical Drug Investigation, 2021, 41 : 115 - 116
  • [25] Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy
    Ten Berg, Jurrien M.
    van den Broek, Wout W. A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (07) : 826 - 828
  • [26] CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention
    Borse, Mrudula S.
    Dong, Olivia M.
    Polasek, Melissa J.
    Farley, Joel F.
    Stouffer, George A.
    Lee, Craig R.
    PHARMACOGENOMICS, 2017, 18 (12) : 1155 - 1166
  • [27] Is there a benefit for CYP2C19 genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients?
    van den Broek, Wout W. A.
    ten Berg, Jurrien M.
    PHARMACOGENOMICS, 2021, 22 (12) : 727 - 730
  • [28] EFFECT OF GENDER ON CLINICAL OUTCOMES IN PATIENTS RECEIVING GENOTYPE-GUIDED ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Gustafson, Chelsea E.
    Williams, Alexis K.
    Pauley, Eric
    Weck, Karen E.
    Lee, Craig R.
    Stouffer, George A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1339 - 1339
  • [29] CYP2C19 Genotype-Guided Antiplatelet Therapy in Stroke Patients-Is It Ready for Prime Time?
    Shao, Danwei
    Mosha, Joyce
    Patel, Rajiv C.
    Lee, Craig R.
    Stouffer, George A.
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (06) : 1079 - 1081
  • [30] Impact of theCYP2C19*17Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
    Lee, Craig R.
    Thomas, Cameron D.
    Beitelshees, Amber L.
    Tuteja, Sony
    Empey, Philip E.
    Lee, James C.
    Limdi, Nita A.
    Duarte, Julio D.
    Skaar, Todd C.
    Chen, Yiqing
    Cook, Kelsey J.
    Coons, James C.
    Dillon, Chrisly
    Franchi, Francesco
    Giri, Jay
    Gong, Yan
    Kreutz, Rolf P.
    McDonough, Caitrin W.
    Stevenson, James M.
    Weck, Karen E.
    Angiolillo, Dominick J.
    Johnson, Julie A.
    Stouffer, George A.
    Cavallari, Larisa H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (03) : 705 - 715